140 related articles for article (PubMed ID: 18545239)
1. Cytokines following SCT: indications and controversies.
Badell I;
Bone Marrow Transplant; 2008 Jun; 41 Suppl 2():S27-9. PubMed ID: 18545239
[TBL] [Abstract][Full Text] [Related]
2. Hematopoietic growth factors including keratinocyte growth factor in allogeneic and autologous stem cell transplantation.
Seggewiss R; Einsele H
Semin Hematol; 2007 Jul; 44(3):203-11. PubMed ID: 17631184
[TBL] [Abstract][Full Text] [Related]
3. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
[TBL] [Abstract][Full Text] [Related]
4. Phase I/II randomized trial evaluating the safety and clinical effects of repifermin administered to reduce mucositis in patients undergoing autologous hematopoietic stem cell transplantation.
Freytes CO; Ratanatharathorn V; Taylor C; Abboud C; Chesser N; Restrepo A; Arango J; Odenheimer D
Clin Cancer Res; 2004 Dec; 10(24):8318-24. PubMed ID: 15623608
[TBL] [Abstract][Full Text] [Related]
5. The influence of palifermin (Kepivance) on oral mucositis and acute graft versus host disease in patients with hematological diseases undergoing hematopoietic stem cell transplant.
Nasilowska-Adamska B; Rzepecki P; Manko J; Czyz A; Markiewicz M; Federowicz I; Tomaszewska A; Piatkowska-Jakubas B; Wrzesien-Kus A; Bieniaszewska M; Duda D; Szydlo R; Halaburda K; Szczepinski A; Lange A; Hellman A; Robak T; Skotnicki A; Jedrzejczak WW; Walewski J; Holowiecki J; Komarnicki M; Dmoszynska A; Warzocha K; Marianska B
Bone Marrow Transplant; 2007 Nov; 40(10):983-8. PubMed ID: 17846600
[TBL] [Abstract][Full Text] [Related]
6. Palifermin reduces incidence and severity of oral mucositis in allogeneic stem-cell transplant recipients.
Langner S; Staber P; Schub N; Gramatzki M; Grothe W; Behre G; Rabitsch W; Urban C; Linkesch W; Neumeister P
Bone Marrow Transplant; 2008 Aug; 42(4):275-9. PubMed ID: 18500368
[TBL] [Abstract][Full Text] [Related]
7. Optimal use of G-CSF administration after hematopoietic SCT.
Trivedi M; Martinez S; Corringham S; Medley K; Ball ED
Bone Marrow Transplant; 2009 Jun; 43(12):895-908. PubMed ID: 19363527
[TBL] [Abstract][Full Text] [Related]
8. Oral mucositis.
Scully C; Sonis S; Diz PD
Oral Dis; 2006 May; 12(3):229-41. PubMed ID: 16700732
[TBL] [Abstract][Full Text] [Related]
9. The harvest and use of autologous back-up grafts for graft failure or severe GVHD after allogeneic hematopoietic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation.
Stelljes M; van Biezen A; Slavin S; Olavarria E; Clark RE; Nagler A; Koza V; Kienast J; Niederwieser D; de Witte T; Ruutu T;
Bone Marrow Transplant; 2008 Dec; 42(11):739-42. PubMed ID: 18724394
[TBL] [Abstract][Full Text] [Related]
10. Intracranial hemorrhage following allogeneic hematopoietic stem cell transplantation.
Najima Y; Ohashi K; Miyazawa M; Nakano M; Kobayashi T; Yamashita T; Akiyama H; Sakamaki H
Am J Hematol; 2009 May; 84(5):298-301. PubMed ID: 19338041
[TBL] [Abstract][Full Text] [Related]
11. Stem cell transplantation and hematopoietic growth factors.
Richard S; Schuster MW
Curr Hematol Rep; 2002 Nov; 1(2):103-9. PubMed ID: 12901131
[TBL] [Abstract][Full Text] [Related]
12. Palifermin for prevention of oral mucositis after haematopoietic stem cell transplantation- single centre experience.
Rzepecki P; Sarosiek T; Barzal J; Oborska S; Nurzynski P; Wasko A; Szczylik C
J BUON; 2007; 12(4):477-82. PubMed ID: 18067205
[TBL] [Abstract][Full Text] [Related]
13. [Collection of hematopoietic progenitor cells from healthy donors].
Bojanić I; Cepulić BG; Mazić S
Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
[TBL] [Abstract][Full Text] [Related]
14. Palifermin (Kepivance) for the treatment of oral mucositis in patients with hematologic malignancies requiring hematopoietic stem cell support.
Radtke ML; Kolesar JM
J Oncol Pharm Pract; 2005 Sep; 11(3):121-5. PubMed ID: 16390600
[TBL] [Abstract][Full Text] [Related]
15. The changing role of stem cell transplantation in childhood.
Locatelli F; Giorgiani G; Di-Cesare-Merlone A; Merli P; Sparta V; Moretta F
Bone Marrow Transplant; 2008 Jun; 41 Suppl 2():S3-7. PubMed ID: 18545240
[TBL] [Abstract][Full Text] [Related]
16. A double-blind randomized placebo-controlled study of oral glutamine in the prevention of mucositis in children undergoing hematopoietic stem cell transplantation: a pediatric blood and marrow transplant consortium study.
Aquino VM; Harvey AR; Garvin JH; Godder KT; Nieder ML; Adams RH; Jackson GB; Sandler ES
Bone Marrow Transplant; 2005 Oct; 36(7):611-6. PubMed ID: 16086046
[TBL] [Abstract][Full Text] [Related]
17. Keratinocyte growth factor.
Athar U; Gentile TC
Expert Opin Biol Ther; 2009 Jun; 9(6):779-87. PubMed ID: 19456212
[TBL] [Abstract][Full Text] [Related]
18. Palifermin in children undergoing autologous stem cell transplantation: a matched-pair analysis.
Czyzewski K; Debski R; Krenska A; Wysocki M; Styczynski J
Anticancer Res; 2014 Dec; 34(12):7379-82. PubMed ID: 25503176
[TBL] [Abstract][Full Text] [Related]
19. Palifermin: role in the prevention of chemotherapy- and radiation-induced mucositis.
McDonnell AM; Lenz KL
Ann Pharmacother; 2007 Jan; 41(1):86-94. PubMed ID: 17190850
[TBL] [Abstract][Full Text] [Related]
20. Gut protection by palifermin during autologous haematopoietic SCT.
Johansson JE; Hasséus B; Johansson P; Eklöf C; Ohman D; Stockelberg D
Bone Marrow Transplant; 2009 May; 43(10):807-11. PubMed ID: 19043460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
